1-193249813-T-A

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_024529.5(CDC73):​c.1501T>A​(p.Tyr501Asn) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y501H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

CDC73
NM_024529.5 missense

Scores

4
15

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.81
Variant links:
Genes affected
CDC73 (HGNC:16783): (cell division cycle 73) This gene encodes a tumor suppressor that is involved in transcriptional and post-transcriptional control pathways. The protein is a component of the the PAF protein complex, which associates with the RNA polymerase II subunit POLR2A and with a histone methyltransferase complex. This protein appears to facilitate the association of 3' mRNA processing factors with actively-transcribed chromatin. Mutations in this gene have been linked to hyperparathyroidism-jaw tumor syndrome, familial isolated hyperparathyroidism, and parathyroid carcinoma. [provided by RefSeq, Jul 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CDC73. . Gene score misZ 3.7315 (greater than the threshold 3.09). Trascript score misZ 3.3639 (greater than threshold 3.09). GenCC has associacion of gene with parathyroid gland carcinoma, familial isolated hyperparathyroidism, hyperparathyroidism 2 with jaw tumors, hyperparathyroidism 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.25279564).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CDC73NM_024529.5 linkuse as main transcriptc.1501T>A p.Tyr501Asn missense_variant 16/17 ENST00000367435.5 NP_078805.3 Q6P1J9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CDC73ENST00000367435.5 linkuse as main transcriptc.1501T>A p.Tyr501Asn missense_variant 16/171 NM_024529.5 ENSP00000356405.4 Q6P1J9

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.0051
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
23
DANN
Benign
0.92
DEOGEN2
Benign
0.24
T;T;T
Eigen
Benign
-0.10
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.95
.;D;D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.25
T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.69
N;N;.
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
0.59
.;N;.
REVEL
Benign
0.13
Sift
Benign
0.086
.;T;.
Sift4G
Uncertain
0.049
.;D;.
Polyphen
0.039
B;B;.
Vest4
0.40
MutPred
0.46
Gain of disorder (P = 0.0251);Gain of disorder (P = 0.0251);.;
MVP
0.54
MPC
1.7
ClinPred
0.69
D
GERP RS
5.5
Varity_R
0.40
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-193218943; API